Ingenium Therapeutics announced that it has raised KRW 5,300 million in a round of funding on November 21, 2023. The transaction included participation from new investors Capstone Partners Co., Ltd.,KGROUND Ventures LLC,Laplace Partners Inc. and Daewoodang Healthcare.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,620 KRW | 0.00% |
|
+5.39% | -30.38% |
1st Jan change | Capi. | |
---|---|---|
-30.38% | 36.61M | |
+22.98% | 3.28B | |
+12.82% | 1.77B | |
+9.53% | 1.53B | |
-11.54% | 1.23B | |
+32.74% | 885M | |
+8.58% | 658M | |
+51.02% | 633M | |
-4.17% | 508M | |
+15.68% | 419M |
- Stock Market
- Equities
- A452300 Stock
- News Capstone Partners Co., Ltd.
- Ingenium Therapeutics announced that it has received KRW 5.3 billion in funding from Laplace Partners Inc., Capstone Partners Co., Ltd., KGROUND Ventures LLC and another investor.